Recent 13F filings as of December 2025 show that 109 institutional investors hold a position in Perspective Therapeutics, Inc. (NYSE:CATX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |
| Nicholson Wealth Management Group, LLC | 31 Dec, 2025 | 1,617,993 | -300 | -0.02% | $4,449,481.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,414,522 | -17,965 | -1.25% | $3,890,676.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,406,374 | -1,154,738 | -45.09% | $3,867,528.00 |
| Nuveen, LLC | 31 Dec, 2025 | 1,274,007 | -34,635 | -2.65% | $3,503,519.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,198,644 | 678,976 | 130.66% | $3,296,271.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 1,184,500 | 1,184,500 | 0.00% | $4,989,875.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,141,247 | 36,543 | 3.31% | $3,138,429.00 |
| Patient Square Capital LP | 31 Dec, 2025 | 1,132,815 | 783,492 | 224.29% | $3,115,241.00 |
| Hills Bank & Trust Co | 31 Dec, 2025 | 938,200 | -41,000 | -4.19% | $2,580,050.00 |
| UBS Group AG | 31 Dec, 2025 | 926,331 | 285,188 | 44.48% | $2,547,410.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 663,830 | 258,200 | 63.65% | $1,825,533.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 535,477 | -313 | -0.06% | $1,472,562.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 439,214 | -31,746 | -6.74% | $1,207,839.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 424,519 | -361,304 | -45.98% | $1,167,427.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 406,732 | 406,732 | 0.00% | $1,118,514.00 |
| WealthPlan Investment Management, LLC | 31 Dec, 2025 | 404,071 | 0 | 0.00% | $1,111,195.00 |